Combining the chemotherapy streptozotocin with various mTOR inhibitors was found to effectively target tumors in preclinical studies for pancreatic neuroendocrine tumors (pNETs).
Julie Grisham
Articles by Julie Grisham
Treatment with capecitabine and temozolomide is an effective therapy for patients with metastatic pancreatic neuroendocrine tumors.
Latest Updated Articles
Survival Reaches 90% With Full Resection in Gastroenteropancreatic NETsPublished: October 17th 2015 | Updated:
Capecitabine/Temozolomide Effective in Pancreatic NETsPublished: October 17th 2015 | Updated:
Targeted/Chemo Combo Effective in Preclinical pNETs StudyPublished: October 17th 2015 | Updated: